Wie soll man begutachten ?

Link zum Artikel von Kollege Alexander Kiss in der Schweizerischen Ärztezeitung.

1. Bower JE, Bak K, Berger A, Breitbart W, Escalante CP, Ganz PA et al. Screening, assessment, and management of fatigue in adult survivors of cancer: an American Society of Clinical
oncology clinical practice guideline adaptation. J Clin Oncol 2014;32(17):1840-50.
2. Pachman DR, Price KA, Carey EC. Nonpharmacologic approach to fatigue in patients with cancer. Cancer J 2014;20(5):313-8.
3. Yennurajalingam S, Bruera E. Review of clinical trials of pharmacologic interventions for cancer-related fatigue: focus on psychostimulants and steroids. Cancer J 2014;20(5):319-24.
4. Cramp F, Byron-Daniel J. Exercise for the management of cancer-related fatigue in adults.
Cochrane Database Syst Rev 2012;11:CD006145.
5. Bower JE. Treating cancer-related fatigue: the search for interventions that target those most in need. J Clin Oncol 2012;30(36):4449-50.
6. Spathis A, Dhillan R, Booden D, Forbes K, Vrotsou K, Fife K. Modafinil for the treatment of fatigue in lung cancer: a pilot study. Palliat Med 2009;23(4):325-31.
7. Bruera E, Yennurajalingam S, Palmer JL, Perez-Cruz PE, Frisbee-Hume S, Allo JA et al.
Methylphenidate and/or a nursing telephone intervention for fatigue in patients with advanced cancer: a randomized, placebo-controlled, phase II trial. J Clin Oncol 2013;31(19):2421-7.
8. Gong S, Sheng P, Jin H, He H, Qi E, Chen W et al. Effect of Methylphenidate in Patients with Cancer-Related Fatigue: A Systematic Review and Meta-Analysis. PLoS One 2014;9(1):e84391.
9. Molassiotis A, Bardy J, Finnegan-John J, Mackereth P, Ryder DW, Filshie J et al. Acupuncturefor cancer-related fatigue in patients with breast cancer: a pragmatic randomized controlled trial. J Clin Oncol 2012;30(36):4470-6.
10. van der Lee ML, Garssen B. Mindfulness-based cognitive therapy reduces chronic cancerrelated fatigue: a treatment study. Psychooncology 2010, DOI: 10.1002/pon.1890
11. Grossman P, Kappos L, Gensicke H, D’Souza M, Mohr DC, Penner IK et al. MS quality of life,
depression, and fatigue improve after mindfulness training: a randomized trial. Neurology 2010;75(13):1141-9.
12. Morrow GR, Hickok JT, Roscoe JA, Raubertas RF, Andrews PL, Flynn PJ et al. Differential effects of paroxetine on fatigue and depression: a randomized, double-blind trial from the
University of Rochester Cancer Center Community Clinical Oncology Program. J Clin Oncol2003;21(24):4635-41.
13. Deutsche Rentenversicherung. Leitlinien für die sozialmedizinische Begutachtung,
Leistungsfähigkeit bei Mamma-Karzinom (18.01.2011) Im Internet: http://www.deutscherentenversicherung.
14. Jansen L, Herrmann A, Stegmaier C, Singer S, Brenner H, Arndt V. Health-related quality of
life during the 10 years after diagnosis of colorectal cancer: a population-based study. J Clin Oncol 2011;29(24):3263-9.
15. Andrykowski MA, Donovan KA, Laronga C, Jacobsen PB. Prevalence, predictors, and
characteristics of off-treatment fatigue in breast cancer survivors. Cancer 2010;116(24):5740-8.
16. Thong MS, Mols F, Wang XS, Lemmens VE, Smilde TJ, van de Poll-Franse LV. Quantifying
fatigue in (long-term) colorectal cancer survivors: a study from the population-based patient
reported outcomes following initial treatment and long term evaluation of survivorship
registry. Eur J Cancer 2013;49(8):1957-66.
17. Horneber M, Fischer I, Dimeo F, Ruffer JU, Weis J. Cancer-related fatigue: epidemiology,
pathogenesis, diagnosis, and treatment. Dtsch Arztebl Int 2012;109(9):161-71; quiz 72.
18. Bower JE, Garet D, Sternlieb B, Ganz PA, Irwin MR, Olmstead R et al. Yoga for persistent
fatigue in breast cancer survivors: A randomized controlled trial. Cancer 2011, DOI:10.1002/cncr.26702
19. Kiss TL, Abdolell M, Jamal N, Minden MD, Lipton JH, Messner HA. Long-term medical
outcomes and quality-of-life assessment of patients with chronic myeloid leukemia followed
at least 10 years after allogeneic bone marrow transplantation. J Clin Oncol 2002;20(9):2334-43.
20. Cella D, Davis K, Breitbart W, Curt G. Cancer-related fatigue: prevalence of proposed
diagnostic criteria in a United States sample of cancer survivors. J Clin Oncol